Zymeworks (ZYME) News Today

Vanguard Group Inc. raised its holdings in Zymeworks Inc. (NYSE:ZYME - Free Report) by 2.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,458,105 shares of the company's stock after acquiring an additi

Zymeworks (NYSE:ZYME - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.01. The company had revenue of $19.24 million for the quarter, compared to analyst estimates of $23.16 million. Zymeworks had a negative net margin of 249.63% and a negative return on equity of 28.37%. During the same period last year, the business posted ($0.76) EPS.

Stifel Nicolaus lifted their price target on Zymeworks from $20.00 to $21.00 and gave the company a "buy" rating in a report on Friday.

Zymeworks (NYSE:ZYME) Shares Gap Up Following Better-Than-Expected Earnings

O Shaughnessy Asset Management LLC grew its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 51.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 255,497 shares of the company's stock after b

Jupiter Asset Management Ltd. lessened its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 13.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 426,944 shares of the company's stock after selling 68,638 shares durin

Picton Mahoney Asset Management decreased its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 20.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 284,378 shares of the company's stock after selling 72,528 shares during the period. Picto

Zymeworks (NYSE:ZYME) Shares Gap Down to $10.35

Susquehanna Fundamental Investments LLC acquired a new stake in Zymeworks Inc. (NYSE:ZYME - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The firm acquired 55,079 shares of the company's stock, valued at approximately $579,000. Susquehanna Fundame

Zymeworks Inc. (NYSE:ZYME - Free Report) - Research analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Zymeworks in a research report issued on Tuesday, June 18th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of (

Perceptive Advisors LLC lessened its position in Zymeworks Inc. (NYSE:ZYME - Free Report) by 25.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,074,807 shares of the company's stock after selling 371,316 shares during the

Zymeworks (NYSE:ZYME) Trading 5.7% Higher

Rubric Capital Management LP increased its position in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 31.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,475,384 shares of the company's stock after acquiring an

HC Wainwright restated a "neutral" rating and set a $10.00 target price on shares of Zymeworks in a research report on Thursday.

Zymeworks (NYSE:ZYME) Stock Price Up 8.4%

Assenagon Asset Management S.A. acquired a new stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 166,549 shares of the company's stock,

Citigroup dropped their price target on Zymeworks from $17.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday.